Ta. Braciak et al., CONSTRUCTION OF RECOMBINANT HUMAN TYPE-5 ADENOVIRUSES EXPRESSING RODENT IL-6 GENES - AN APPROACH TO INVESTIGATE IN-VIVO CYTOKINE FUNCTION, The Journal of immunology, 151(10), 1993, pp. 5145-5153
The majority of biologic functions assigned to cytokines have been cha
racterized by in vitro assay systems which may not necessarily reflect
cytokine roles in vivo. Recently, recombinant virus approaches have a
llowed tissue-specific expression of foreign gene products in experime
ntal animal models. We have constructed recombinant human type 5 adeno
viruses, deficient in the E3 region of the genome, with incorporated r
odent IL-6 cDNA that express significant levels of biologically active
IL-6 on infection both in vitro and in vivo. After i.p. injection, th
e liver, spleen, and peritoneum appear to be primary sites of expressi
on, whereas the lung and bronchus are the main sites of expression aft
er intratracheal instillation. Injection i.p. of BALB/c mice with the
murine rIL-6 virus causes an increase in serum levels of bioactive IL-
6 for up to 6 days post-infection, whereas similar changes are not see
n in animals infected with control viruses. Coincident with enhanced p
lasma levels of IL-6, we detect raised serum levels of hepatic-derived
acute phase proteins. Associated with the expression of IL-6 in the l
iver and spleen, at 7 days we note a fourfold splenomegaly with expans
ion of B and T cell compartments, as well as the presence of lymphoid
aggregates in the liver. These morphologic changes had resolved by 16
days. Our findings demonstrate that recombinant human type 5 adenoviru
ses expressing cDNA for various cytokines could be used as a transient
pseudo-transgenic animal model to investigate the biologic function o
f cytokines in vivo.